Add this result to my export selection Revised SPC: Cardicor (bisoprolol) tablets Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 18 November 2020 Angioedema has been added as a potential adverse effect of treatment (frequency – rare). Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPCs: Ropilynz (ropinirole hydrochloride) XL Prolonged-release Tablets (all strengths) Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 16 November 2020 To discontinue treatment in patients with Parkinson's disease, ropinirole should be tapered off, as patients with impulse control disorders and those receiving high daily dose and/or cumulative doses... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPCs: Simponi (golimumab) solution for injection in pre-filled pen or syringe (all strengths) Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 16 November 2020 SPCs updated to include Kaposi’s sarcoma (a rare type of cancer caused by a virus, which can affect the skin and mouth and potentially the internal organs) as an adverse effect of treatment of... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Yervoy (ipilimumab) 5 mg/ml concentrate for solution for infusion Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 24 November 2020 SPC revised with licence extension to include use in combination with nivolumab and 2 cycles of platinum-based chemotherapy for the first-line treatment of metastatic non-small cell lung cancer in... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Opdivo (nivolumab) 10 mg/mL concentrate for solution for infusion Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 23 November 2020 SPC revised with licence extension to include use in combination with ipilimumab and 2 cycles of platinum-based chemotherapy for the first-line treatment of metastatic non-small cell lung cancer in... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Galzemic (galantamine hydrobromide) 4 mg/ml Oral Solution Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 23 November 2020 SPC warns galantamine can cause bradycardia (common) and all types of atrioventricular node block (rare); and galantamine bioavailability increases during co-administration of paroxetine (CYP2D6... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPCs: Ovitrelle (choriogonadotropin alfa) 250 micrograms/0.5 ml prefilled syringe or pen Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 23 November 2020 SPC updated to include rash as a very rare (<1/10,000) immune system disorder related reaction to treatment with choriogonadotropin alfa in the treatment of anovulatory or oligo-ovulatory adult women. Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPCs: Kalydeco (ivacaftor) granules in sachet – all strengths Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 23 November 2020 SPCs updated to include extension of licence, to include treatment of patients with cystic fibrosis, aged at least 4 months, weighing 5 kg to less than 25 kg, with revisions in various sections to... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Fycompa (perampanel)– all presentations Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 20 November 2020 SPC updated to include details for the licence extension adjunctive use in children aged 4 years, and for partial-onset seizures and from 7 years for idiopathic generalised epilepsy. Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Cerazette (desogestrel) 75 microgram film-coated tablet Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 20 November 2020 SPC now states that Cerazette can be used during breastfeeding although infrequent post marketing reports suggest a decrease in milk production. Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)